EQT
51
4
TMO
56
-11
NI
63
-2
RRC
62
-16
DAL
70
-2
EIX
56
2
LEN
36
-5
FCX
74
2
TGNA
58
-22
WHR
53
-11
AMG
71
-3
ADI
70
-6
AAL
51
-6
VNO
52
-13
IVZ
68
2
A
40
-3
EW
53
-4
EMC
76
22
NEE
50
-4
SHW
53
-14
EQT
51
4
TMO
56
-11
NI
63
-2
RRC
62
-16
DAL
70
-2
EIX
56
2
LEN
36
-5
FCX
74
2
TGNA
58
-22
WHR
53
-11
AMG
71
-3
ADI
70
-6
AAL
51
-6
VNO
52
-13
IVZ
68
2
A
40
-3
EW
53
-4
EMC
76
22
NEE
50
-4
SHW
53
-14
Financhill
Back

BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
62

ZSU.TO
BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF

Last Price:
$13.43
Seasonality Move:
-0.6%
Sell
29

ZBIO
Zenas BioPharma, Inc.

Last Price:
$37.07
Seasonality Move:
0.59%
Buy
62
BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF (ZSU.TO) is a Buy

Is BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF a Buy, Sell or Hold?

  • The current BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF [ZSU.TO] share price is $13.43. The Score for ZSU.TO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ZSU.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ZSU.TO Stock Price Chart

What is BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF's stock price today?

  • The BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF share price today is $13.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZSU.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $35.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.

ZSU.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.07 Buy
Relative Strength Index (14 RSI): 51.68 Buy
Chaikin Money Flow: 50499 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.4 - 13.44) Buy
Bollinger Bands (100): (13.42 - 13.5) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.86 Buy
Relative Strength Index (14 RSI): 49.55 Sell
Chaikin Money Flow: -89322 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.22 - 39.36) Sell
Bollinger Bands (100): (17.16 - 33.88) Buy

ZSU.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.41 Buy
20-day SMA: 13.42 Buy
50-day SMA: 13.44 Sell
200-day SMA: 13.42 Buy
8-day EMA: 2.98 Buy
20-day EMA: 1.28 Buy
50-day EMA: 0.53 Buy
200-day EMA: 0.13 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.84 Sell
20-day SMA: 37.69 Sell
50-day SMA: 32.84 Buy
200-day SMA: 17.75 Buy
8-day EMA: 7.96 Buy
20-day EMA: 3.41 Buy
50-day EMA: 1.4 Buy
200-day EMA: 0.36 Buy

BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF Earnings Growth & ZSU.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

BMO Short-Term US IG Corp Bond Hgd to CAD Inx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):